Detalles de la búsqueda
1.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31568564
2.
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.
Oncologist
; 24(7): 955-962, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30568021
3.
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
Blood
; 128(18): 2199-2205, 2016 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27601462
4.
Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis.
Haematologica
; 103(5): 874-879, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29419429
5.
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Haematologica
; 103(9): 1511-1517, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29880613
6.
Evaluation of direct oral anticoagulants for the treatment of venous thromboembolism in the oncology population.
J Thromb Thrombolysis
; 46(4): 483-487, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30191357
7.
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Blood
; 124(15): 2354-61, 2014 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25161267
8.
Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pain.
J Oncol Pharm Pract
; 22(1): 114-20, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25227231
9.
Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.
Br J Haematol
; 170(4): 504-14, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25907897
10.
Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia.
Am J Hematol
; 90(6): 487-92, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25691474
11.
Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study.
Br J Haematol
; 181(2): 259-261, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28220935
12.
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
J Clin Oncol
; 35(20): 2260-2267, 2017 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28475457
13.
A Multidisciplinary Approach to Standardizing Processes for Blinatumomab Administration.
Clin J Oncol Nurs
; 20(5): 466-9, 2016 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27668365
14.
Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma.
Leuk Lymphoma
; 54(12): 2606-12, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23488604
Resultados
1 -
14
de 14
1
Próxima >
>>